The Proportion of Preventable Thrombectomy Procedures with Improved Atrial Fibrillation Stroke Prevention
- PMID: 33545519
- DOI: 10.1016/j.jstrokecerebrovasdis.2021.105599
The Proportion of Preventable Thrombectomy Procedures with Improved Atrial Fibrillation Stroke Prevention
Abstract
Background: Large vessel occlusion (LVO) strokes can in part be prevented with better atrial fibrillation (AF) stroke prevention strategies; thus we evaluated the rate of AF in patients presenting with acute LVO strokes undergoing mechanical thrombectomy (MT) and assessed patterns of oral anticoagulant (OAC) use prior to the index stroke.
Methods and results: We identified 347 MT cases from February 2015 to September 2018. A retrospective chart review was conducted to identify patient sociodemographics, presence of AF, use of anticoagulation, stroke severity, CHA2DS2-VASc scores, and functional outcomes. AF was present in 161 (46%) cases. Patients with AF were older (mean 76 ± 11 years vs. 66 ± 15 years) and more likely to be female (56% vs. 46%) with higher rates of hypertension, dyslipidemia, heart failure and smoking. Of the 100 patients with known AF, 59 were not on anticoagulation prior to the index stroke. Of 39 patients with known AF on OAC, 57% were not therapeutic on warfarin and 20% were not taking prescribed direct OACs. A total of 72 (21%) thrombectomy cases were performed on patients with known AF who were not effectively anticoagulated. After multivariate adjustments, there was no significant difference in modified Rankin Scale score at discharge, in-hospital mortality, or symptomatic intracranial hemorrhage between the AF and non-AF groups.
Conclusion: In our study, 21% of patients with LVO stroke had known AF and were not effectively anticoagulated. Improved stroke preventive measures could potentially reduce the occurrence of stroke and avoid unnecessary procedures for patients with AF.
Keywords: Anticoagulation; Atrial fibrillation; Endovascular therapy; Ischemic stroke; Primary prevention; Secondary prevention.
Copyright © 2021 Elsevier Inc. All rights reserved.
Similar articles
-
Atrial Fibrillation Treatment Adequacy and Outcome after Endovascular Thrombectomy.J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104948. doi: 10.1016/j.jstrokecerebrovasdis.2020.104948. Epub 2020 Jun 5. J Stroke Cerebrovasc Dis. 2020. PMID: 32689630
-
Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.Prog Cardiovasc Dis. 2015 Sep-Oct;58(2):177-94. doi: 10.1016/j.pcad.2015.07.003. Epub 2015 Jul 7. Prog Cardiovasc Dis. 2015. PMID: 26162958 Review.
-
Anticoagulation Protocol for Secondary Prevention of Acute Ischemic Stroke Associated with Nonvalvular Atrial Fibrillation.J Stroke Cerebrovasc Dis. 2021 Aug;30(8):105893. doi: 10.1016/j.jstrokecerebrovasdis.2021.105893. Epub 2021 Jun 6. J Stroke Cerebrovasc Dis. 2021. PMID: 34107414
-
Temporal Trends in Pharmacological Stroke Prevention in Patients with Acute Ischemic Stroke and Known Atrial Fibrillation.J Stroke Cerebrovasc Dis. 2020 Dec;29(12):105266. doi: 10.1016/j.jstrokecerebrovasdis.2020.105266. Epub 2020 Sep 10. J Stroke Cerebrovasc Dis. 2020. PMID: 32992191
-
Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.J Am Heart Assoc. 2017 Jul 18;6(7):e005835. doi: 10.1161/JAHA.117.005835. J Am Heart Assoc. 2017. PMID: 28720644 Free PMC article. Review.
Cited by
-
Atrial Fibrillation and Clinical Outcomes of Endovascular Thrombectomy for Acute Ischemic Stroke: A Meta-Analysis of Adjusted Effect Estimates.J Am Heart Assoc. 2023 Dec 19;12(24):e031733. doi: 10.1161/JAHA.123.031733. Epub 2023 Dec 18. J Am Heart Assoc. 2023. PMID: 38108252 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical